1. Home
  2. ITCI vs JXN Comparison

ITCI vs JXN Comparison

Compare ITCI & JXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITCI
  • JXN
  • Stock Information
  • Founded
  • ITCI 2002
  • JXN 1961
  • Country
  • ITCI United States
  • JXN United States
  • Employees
  • ITCI N/A
  • JXN N/A
  • Industry
  • ITCI Biotechnology: Pharmaceutical Preparations
  • JXN Life Insurance
  • Sector
  • ITCI Health Care
  • JXN Finance
  • Exchange
  • ITCI Nasdaq
  • JXN Nasdaq
  • Market Cap
  • ITCI 8.0B
  • JXN 7.4B
  • IPO Year
  • ITCI N/A
  • JXN N/A
  • Fundamental
  • Price
  • ITCI $84.69
  • JXN $99.04
  • Analyst Decision
  • ITCI Strong Buy
  • JXN Hold
  • Analyst Count
  • ITCI 12
  • JXN 5
  • Target Price
  • ITCI $97.67
  • JXN $91.40
  • AVG Volume (30 Days)
  • ITCI 747.9K
  • JXN 722.2K
  • Earning Date
  • ITCI 10-30-2024
  • JXN 11-06-2024
  • Dividend Yield
  • ITCI N/A
  • JXN 2.84%
  • EPS Growth
  • ITCI N/A
  • JXN N/A
  • EPS
  • ITCI N/A
  • JXN N/A
  • Revenue
  • ITCI $613,728,000.00
  • JXN $4,004,000,000.00
  • Revenue This Year
  • ITCI $48.25
  • JXN N/A
  • Revenue Next Year
  • ITCI $38.47
  • JXN $2.73
  • P/E Ratio
  • ITCI N/A
  • JXN N/A
  • Revenue Growth
  • ITCI 46.08
  • JXN 2041.18
  • 52 Week Low
  • ITCI $58.14
  • JXN $45.57
  • 52 Week High
  • ITCI $93.45
  • JXN $115.22
  • Technical
  • Relative Strength Index (RSI)
  • ITCI 55.47
  • JXN 46.29
  • Support Level
  • ITCI $81.83
  • JXN $97.51
  • Resistance Level
  • ITCI $86.36
  • JXN $100.11
  • Average True Range (ATR)
  • ITCI 2.47
  • JXN 3.92
  • MACD
  • ITCI -0.76
  • JXN -1.36
  • Stochastic Oscillator
  • ITCI 30.64
  • JXN 9.16

About ITCI Intra-Cellular Therapies Inc.

Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.

About JXN Jackson Financial Inc.

Jackson Financial Inc helps Americans grow and protect their retirement savings and income to enable them to pursue financial freedom for life. Its retail products offerings comprise annuities, designed to help retail investors save for and live in retirement. Its diverse suite of annuities includes a variable, fixed index, and fixed annuities. It manages the business through three segments: Retail Annuities, Institutional Products, and Closed Life and Annuity Blocks and Corporate and Other segments.

Share on Social Networks: